mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.2 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.2 |
mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.2 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |